Bicocca Open Archive

Logo unimib boa
MAGISTRONI, VERA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.471
AS - Asia 3.049
EU - Europa 3.014
SA - Sud America 428
AF - Africa 77
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 10
Totale 13.060
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.296
SG - Singapore 1.056
CN - Cina 722
DE - Germania 612
VN - Vietnam 423
SE - Svezia 404
RU - Federazione Russa 399
IT - Italia 390
IE - Irlanda 356
HK - Hong Kong 350
BR - Brasile 311
UA - Ucraina 232
GB - Regno Unito 200
CA - Canada 125
FR - Francia 123
IN - India 114
FI - Finlandia 89
TR - Turchia 59
BD - Bangladesh 57
KR - Corea 47
AR - Argentina 43
IQ - Iraq 38
PL - Polonia 35
BE - Belgio 34
ID - Indonesia 33
NL - Olanda 33
ZA - Sudafrica 33
MX - Messico 30
DK - Danimarca 28
ES - Italia 26
JP - Giappone 24
CO - Colombia 20
SA - Arabia Saudita 20
PK - Pakistan 17
EC - Ecuador 14
VE - Venezuela 13
NP - Nepal 12
PH - Filippine 12
AU - Australia 11
AT - Austria 10
LT - Lituania 10
UZ - Uzbekistan 10
BG - Bulgaria 9
EU - Europa 9
CL - Cile 8
JO - Giordania 8
MA - Marocco 8
PE - Perù 8
EG - Egitto 7
KE - Kenya 7
CH - Svizzera 6
CZ - Repubblica Ceca 6
IR - Iran 6
JM - Giamaica 6
AZ - Azerbaigian 5
BO - Bolivia 5
DO - Repubblica Dominicana 5
ET - Etiopia 5
IL - Israele 5
MY - Malesia 5
TN - Tunisia 5
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
DZ - Algeria 3
HN - Honduras 3
KG - Kirghizistan 3
LB - Libano 3
MU - Mauritius 3
NO - Norvegia 3
OM - Oman 3
RO - Romania 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
LY - Libia 2
MG - Madagascar 2
RS - Serbia 2
TH - Thailandia 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BW - Botswana 1
CI - Costa d'Avorio 1
GE - Georgia 1
HU - Ungheria 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MT - Malta 1
NI - Nicaragua 1
PA - Panama 1
PS - Palestinian Territory 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
Totale 13.060
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.035
Ashburn 626
Singapore 619
Woodbridge 445
Chandler 354
Dublin 348
Hong Kong 342
Fairfield 332
San Jose 327
Frankfurt am Main 274
Houston 269
Jacksonville 224
Wilmington 209
Dearborn 205
Milan 168
New York 164
Seattle 129
Los Angeles 120
Beijing 119
Ho Chi Minh City 119
Santa Clara 110
Cambridge 107
Göttingen 91
Princeton 91
Hanoi 89
Dallas 85
Chicago 81
Shanghai 80
The Dalles 72
Nanjing 61
Hefei 49
Lauterbourg 43
Altamura 41
Munich 41
Seoul 40
São Paulo 40
Lachine 38
Moscow 36
Lawrence 35
Brussels 34
Fürstenwalde 32
Helsinki 30
Boardman 29
Toronto 28
Warsaw 28
Dong Ket 27
Buffalo 26
San Diego 26
Fremont 25
London 25
Shenyang 24
Orem 23
Da Nang 21
Jakarta 21
Montreal 21
Tianjin 20
Tokyo 20
Council Bluffs 19
Andover 18
Guangzhou 17
Johannesburg 17
Changsha 16
Chennai 16
Ottawa 16
Baghdad 15
Nuremberg 15
Atlanta 14
Huizen 14
Brooklyn 13
Haiphong 13
Hebei 13
Jinan 13
Manchester 13
Nanchang 13
Boston 12
Jiaxing 12
Stockholm 12
Turku 12
Denver 11
Mumbai 11
Pune 11
Can Tho 10
Kunming 10
Lissone 10
San Francisco 10
Ankara 9
Falls Church 9
Mexico City 9
Rome 9
Romola 9
Salt Lake City 9
Tashkent 9
Amman 8
Amsterdam 8
Belo Horizonte 8
Brasília 8
Buenos Aires 8
Düsseldorf 8
Kocaeli 8
Norwalk 8
Totale 8.621
Salva come PNG Salva come JPEG
Nome #
De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways 599
BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene 458
OncoScore: A novel, Internet-based tool to assess the oncogenic potential of genes 451
RNA-seq is a valuable complement of conventional diagnostic tools in newly diagnosed AML patients 443
SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub 410
Recurrent SETBP1 mutations in atypical chronic myeloid leukemia 407
Three novel patients derived BCR/ABL mutants show different sensitivity to second and third generation tyrosine kinase inhibitors 393
Erratum: OncoScore: a novel, Internet-based tool to assess the oncogenic potential of genes 389
Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia 375
Recurrent ETNK1 mutations in atypical chronic myeloid leukemia 357
In vitro and in vivo activity of SKI-606, a novel Src-Abl inhibitor, against imatinib-resistant Bcr-Abl+ neoplastic cells 344
Evidence of ETNK1 Somatic Variants in Atypical Chronic Myeloid Leukemia 342
ERG deregulation induces PIM1 over-expression and aneuploidy in prostate epithelial cells 328
Response to ‘D276G mutation is associated with a poor prognosis in imatinib mesylate-resistant chronic myeloid leukemia patients’ by leguay et al 318
Identification of novel point mutations in splicing sites integrating whole-exome and RNA-seq data in myeloproliferative diseases 313
Activity of bosutinib, dasatinib, and nilotinib against 18 imatinib-resistant BCR/ABL mutants 312
Epigenetic silencing of BIM in glucocorticoid poor-responsive pediatric acute lymphoblastic leukemia, and its reversal by histone deacetylase inhibition 311
Oncoscore, a Novel, Internet-Based Tool to Assess the Oncogenic Potential of Genes Can Differentiate Between CP-CML and BC-CML Associated Genes, and Between CP-CML Patients with Good and Bad Prognosis 308
CEQer: A Graphical Tool for Copy Number and Allelic Imbalance Detection from Whole-Exome Sequencing Data 306
Epigenetic Silencing of the Proapoptotic Gene BIM in Anaplastic Large Cell Lymphoma through an MeCP2/SIN3a Deacetylating Complex 303
Integrated Analysis of Whole-Exome Sequencing and Micrornas Expression in Blast Crisis Transformation of Chronic Myeloid Leukemia 302
Recurrent SETBP1 Mutations in Atypical Chronic Myeloid Leukemia 296
Evidence for D276G and L364I Bcr-Abl mutations in Ph plus leukaemic cells obtained from patients resistant to Imatinib 291
FusionAnalyser: a new graphical, event-driven tool for fusion rearrangements discovery 274
Identification of a Novel Splicing Mutation in Blast Crisis Transformation of Chronic Myeloid Leukemia Integrating Whole-exome and RNA-Seq data 270
Synergistic drug combinations prevent resistance in ALK+ anaplastic large cell lymphoma 263
Recurrent KIT D816V Mutation in Atypical Chronic Myeloid Leukemia 260
The achievement of durable complete cytogenetic remission in late chronic and accelerated phase patients with CML treated with Imatinib mesylate predicts for prolonged response at 6 years 252
Epigenetic Silencing of the Pro-Apoptotic Bim Gene in Glucocorticoid Poor-Responsive Pediatric Acute Lymphoblastic Leukemia, and Its Reversal by Histone Deacetylase Inhibition 248
Whole-exome sequencing of matched chronic phase and blast crisis CML samples to reveal mechanisms of blast crisis transformation 247
Colorectal tumors are effectively eradicated by combined inhibition of {beta}-catenin, KRAS, and the oncogenic transcription factor ITF2 246
Determination of the Activity Profile of Bosutinib, Dasatinib and Nilotinib against 18 Imatinib Resistant Bcr/Abl Mutants 245
Valproic acid enhances bosutinib cytotoxicity in colon cancer cells 244
Mechanisms of resistance to imatinib in chronic myeloid leukemia (CML) patients in chronic phase (CP) who achieved durable complete cytogenetic responses (CCR) 219
In vitro and in vivo activity of SKI-606, a novel Abl/Src inhibitor, against imatinib resistant BCR-ABL plus neoplastic 215
BIM promoter is epigenetically silenced in malignant lymphoid cells, leading to downregulation of BIM expression and protection from apoptosis 210
ERG deregulation induces IGF-1R expression in prostate cancer cells and affects sensitivity to anti-IGF-1R agents 199
The novel PIM1 inhibitor NMS-P645 reverses PIM1-Dependent effects on TMPRSS2/ERG positive Prostate cancer cells and shows anti-proliferative activity in combination with PI3K inhibition 198
Imatinib dose increase up to 1200 mg daily can induce new durable complete cytogenetic remissions in relapsed Ph+ chronic myeloid leukemia patients 194
Mechanisms of Bim epigenetic silencing in anaplastic large cell lymphoma 194
Synergistic drug combinations preventdrug resistance in anaplastic large cell lymphomapreclinical models 183
Bim promoter is highly methylated in malignant lymphoid cell lines, leading to downregulation of Bim expression and protection from apoptosis 170
Epigenetic changes at the bim locus associated with glucocorticoid resistance in human lymphoid malignancies 166
Reactivation of an Epigenetic Silenced Tumor Suppressor Gene BIM in Anaplastic Large Cell Lymphoma Leads to massive Apoptosis 165
Reversal of glucocorticoid resistance in human lymphoid malignancies with histone deacetylase inhibitors 164
Role of TMPRSS2/ERG in cellular transformation 160
Totale 13.342
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.003
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.003
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021154 0 0 0 0 0 0 0 0 0 0 63 91
2021/2022687 47 67 103 45 47 62 38 32 32 61 47 106
2022/20231.298 157 426 113 127 94 181 15 64 87 5 19 10
2023/2024930 23 32 33 47 126 285 205 15 59 16 4 85
2024/20251.716 112 190 108 102 156 58 102 31 124 314 156 263
2025/20264.141 503 222 359 564 568 218 671 173 362 452 49 0
Totale 13.342